Reference Source

Ipca Laboratories Limited · 66-41 · INDIA

For Ipca Laboratories Limited · 66-41 · INDIA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is INDIA; product code is 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 09/30/2009; address is P.O. Sejavta , Ratlam, Madhya Pradesh INDIA, verified against its source on 2026-09-16.

Firm
Ipca Laboratories Limited verified
Import alert
66-41
Import alert name
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
Country
INDIA verified
Address
P.O. Sejavta , Ratlam, Madhya Pradesh INDIA verified
Date published
09/30/2009 verified
Product code
66 V - - 99 Miscellaneous Patent Medicines, Etc. verified
FDA notes
8/22/2008. Piccan Teething Remedy. The combination of paracetamol (acetaminophen) and diphenhydramine has not been evaluated under the OTC Drug Review for use in relieving children's teething pain and associated troubles. The labeling contains structure/function claims; such as using the product to relieve childrens teething pains; making this product a drug under 201(g)(1) of the FFDCA. Further; we are not aware that this drug is generally accepted as safe and effective for its labeled uses. Consequently; this drug appears to be a new drug. verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Ipca Laboratories Limited Date Published : 09/30/2009 P.O. Sejavta , Ratlam, Madhya Pradesh INDIA 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 09/30/2009 Notes: 8/22/2008. Piccan Teething Remedy. The combination of paracetamol (acetaminophen) and diphenhydramine has not been evaluated under the OTC Drug Review for use in relieving children's teething pain and associated troubles. The labeling contains structure/function claims; such as using the product to relieve childrens teething pains; making this product a drug under 201(g)(1) of the FFDCA. Further; we are not aware that this drug is generally accepted as safe and effective for its labeled uses. Consequently; this drug appears to be a new drug.

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.